Loading…
Novel phantom for performance evaluation of contrast-enhanced 3D rotational angiography
•The need for dedicated phantom for 3DRA is confirmed.•An in-house phantom for 3DRA image quality evaluation is introduced.•The phantom serves as MTF and NPS measurement tool in 3D angiography.•Iodine-filled module is present in the phantom to allow task-based evaluation. This technical note present...
Saved in:
Published in: | Physica medica 2021-10, Vol.90, p.91-98 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | •The need for dedicated phantom for 3DRA is confirmed.•An in-house phantom for 3DRA image quality evaluation is introduced.•The phantom serves as MTF and NPS measurement tool in 3D angiography.•Iodine-filled module is present in the phantom to allow task-based evaluation.
This technical note presents an in-house phantom with a specially designed contrast-object module constructed to address the need for three-dimensional rotational angiography (3DRA) testing.
The initial part of the study was a brief evaluation on the commercially available phantom used for 3DRA and computed tomography angiography (CTA) to confirm the need for a special phantom for 3D angiography. Once confirmed, an in-house phantom was constructed. The novel phantom was tested to evaluate the basic image performance metrics, i.e., unsharpness (MTF) and noise characterization (NPS), as well as to show its capability for vessel contrast visibility study.
The low contrast objects in the commercially available tools dedicated for CT is found to yield significantly lower signal difference to noise ratio (SDNR) when used for 3DRA, therefore deemed inadequate for 3DRA contrast evaluation. The constructed in-house phantom demonstrates a capability to serve for basic imaging performance check (MTF, NPS, and low contrast evaluation) for 3DRA and CTA. With higher and potentially adjustable visibility of contrast objects as artificial vessels, the in-house phantom also makes more clinically relevant tests, e.g., human- or model observer study and task-based optimization, possible.
The novel phantom with special contrast object module shows higher visibility in 3DRA compared to the currently available commercial phantom and, therefore, is recommended for use in 3D angiography. |
---|---|
ISSN: | 1120-1797 1724-191X |
DOI: | 10.1016/j.ejmp.2021.09.002 |